1. Home
  2. FBIO vs ACOG Comparison

FBIO vs ACOG Comparison

Compare FBIO & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

HOLD

Current Price

$4.01

Market Cap

113.9M

Sector

Health Care

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$6.49

Market Cap

115.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBIO
ACOG
Founded
2006
2000
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
113.9M
115.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FBIO
ACOG
Price
$4.01
$6.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$16.50
$18.00
AVG Volume (30 Days)
560.7K
106.2K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$62,303,000.00
$7,427,199.00
Revenue This Year
$29.71
N/A
Revenue Next Year
$49.34
$132.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$3.75
52 Week High
$4.20
$11.54

Technical Indicators

Market Signals
Indicator
FBIO
ACOG
Relative Strength Index (RSI) 75.05 58.35
Support Level $3.54 $5.61
Resistance Level $3.81 $6.91
Average True Range (ATR) 0.24 0.54
MACD 0.04 0.13
Stochastic Oscillator 94.82 78.74

Price Performance

Historical Comparison
FBIO
ACOG

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: